Published in Neurodegener Dis on December 20, 2013
Minocycline upregulates cyclic AMP response element binding protein and brain-derived neurotrophic factor in the hippocampus of cerebral ischemia rats and improves behavioral deficits. Neuropsychiatr Dis Treat (2015) 0.78
Why lithium studies for ALS treatment should not be halted prematurely. Front Neurosci (2014) 0.77
Compartment-dependent mitochondrial alterations in experimental ALS, the effects of mitophagy and mitochondriogenesis. Front Cell Neurosci (2015) 0.76
Downregulation of Homer1b/c in SOD1 G93A Models of ALS: A Novel Mechanism of Neuroprotective Effect of Lithium and Valproic Acid. Int J Mol Sci (2016) 0.75
Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke (2006) 3.28
Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet (2012) 2.69
Identification and broad dissemination of the CTX-M-14 beta-lactamase in different Escherichia coli strains in the northwest area of Spain. J Clin Microbiol (2002) 2.25
Expression of sperm protein 17 (Sp17) in ovarian cancer. Int J Cancer (2004) 1.70
[Meningitis outbreak caused by Echovirus serotype 30 in the Valencian Community]. Enferm Infecc Microbiol Clin (2009) 1.39
Synthesis of 6-amino-1,4-dihydropyridines that prevent calcium overload and neuronal death. Eur J Med Chem (2007) 1.20
Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors. J Med Chem (2011) 1.12
A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors. Bioorg Med Chem Lett (2009) 1.08
Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice. Prog Neuropsychopharmacol Biol Psychiatry (2008) 1.08
Redistribution of Ca2+ among cytosol and organella during stimulation of bovine chromaffin cells. FASEB J (2002) 1.02
Immunomodulatory and anti-inflammatory effects of chondroitin sulphate. J Cell Mol Med (2009) 1.02
Paroxysmal head pain with backward radiation: will epicrania fugax go in the opposite direction? J Headache Pain (2010) 1.00
Synthesis and pharmacology of galantamine. Chem Rev (2006) 0.99
Analysis of the C9orf72 gene in patients with amyotrophic lateral sclerosis in Spain and different populations worldwide. Hum Mutat (2012) 0.99
Improving treatment adherence in your patients with schizophrenia: the STAY initiative. Clin Drug Investig (2013) 0.99
Long-term outcome in chronic inflammatory demyelinating polyneuropathy patients treated with intravenous immunoglobulin: a retrospective study. Muscle Nerve (2013) 0.96
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. J Med Chem (2008) 0.95
Multifocal nummular headache with trophic changes. Headache (2010) 0.95
New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors. Bioorg Med Chem Lett (2010) 0.95
Mitochondria sense with different kinetics the calcium entering into HeLa cells through calcium channels CALHM1 and mutated P86L-CALHM1. Biochem Biophys Res Commun (2009) 0.94
Synthesis and biological evaluation of new 4H-pyrano[2,3-b]quinoline derivatives that block acetylcholinesterase and cell calcium signals, and cause neuroprotection against calcium overload and free radicals. Eur J Med Chem (2006) 0.93
Neuroprotectant minocycline depresses glutamatergic neurotransmission and Ca(2+) signalling in hippocampal neurons. Eur J Neurosci (2007) 0.93
Modulatory mechanism of the endogenous peptide catestatin on neuronal nicotinic acetylcholine receptors and exocytosis. J Neurosci (2002) 0.92
2-Hydroxyoleate, a nontoxic membrane binding anticancer drug, induces glioma cell differentiation and autophagy. Proc Natl Acad Sci U S A (2012) 0.92
Chondroitin sulfate protects SH-SY5Y cells from oxidative stress by inducing heme oxygenase-1 via phosphatidylinositol 3-kinase/Akt. J Pharmacol Exp Ther (2007) 0.92
Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties. J Med Chem (2010) 0.91
SNX482 selectively blocks P/Q Ca2+ channels and delays the inactivation of Na+ channels of chromaffin cells. Eur J Pharmacol (2003) 0.91
Toll-like receptor 4 participates in the myelin disruptions associated with chronic alcohol abuse. Glia (2012) 0.90
Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors. Neuropharmacology (2004) 0.88
Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors. J Pharmacol Exp Ther (2005) 0.87
MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins. Bioorg Med Chem Lett (2011) 0.87
Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties. ChemMedChem (2009) 0.86
Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases. Future Med Chem (2014) 0.86
Asymptomatic cerebrovascular disease and systemic diagnosis in stroke, atherothrombosis as a disease of the vascular tree. Cerebrovasc Dis (2005) 0.85
Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells. J Pineal Res (2010) 0.85
Role of the endoplasmic reticulum and mitochondria on quantal catecholamine release from chromaffin cells of control and hypertensive rats. J Pharmacol Exp Ther (2009) 0.85
Mitochondria and chromaffin cell function. Pflugers Arch (2012) 0.85
Neuroprotective effect of the new thiadiazolidinone NP00111 against oxygen-glucose deprivation in rat hippocampal slices: implication of ERK1/2 and PPARgamma receptors. Exp Neurol (2008) 0.85
Carotid intima-media thickness changes with Mediterranean diet: a randomized trial (PREDIMED-Navarra). Atherosclerosis (2011) 0.85
N-acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease. Eur J Med Chem (2011) 0.85
Phosphodiesterase inhibition induces retinal degeneration, oxidative stress and inflammation in cone-enriched cultures of porcine retina. Exp Eye Res (2013) 0.84
An update on the pharmacology of galantamine. Expert Opin Investig Drugs (2007) 0.84
Amyloid and FDG-PET study of logopenic primary progressive aphasia: evidence for the existence of two subtypes. J Neurol (2015) 0.84
[Incidence, risk factors and influence on survival of infectious complications in liver transplantation]. Enferm Infecc Microbiol Clin (2003) 0.83
Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives. J Med Chem (2010) 0.83
CSF from amyotrophic lateral sclerosis patients produces glutamate independent death of rat motor brain cortical neurons: protection by resveratrol but not riluzole. Brain Res (2011) 0.83
Galantamine postischemia provides neuroprotection and memory recovery against transient global cerebral ischemia in gerbils. J Pharmacol Exp Ther (2007) 0.83
Neurologic complications of intrathecal liposomal cytarabine administered prophylactically to patients with non-Hodgkin lymphoma. J Neurooncol (2010) 0.83
Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors. Bioorg Med Chem Lett (2010) 0.83
Chondroitin sulfate reduces cell death of rat hippocampal slices subjected to oxygen and glucose deprivation by inhibiting p38, NFκB and iNOS. Neurochem Int (2011) 0.82
Old phenothiazine and dibenzothiadiazepine derivatives for tomorrow's neuroprotective therapies against neurodegenerative diseases. Eur J Med Chem (2010) 0.82
Bcl2 mitigates Ca2+ entry and mitochondrial Ca2+ overload through downregulation of L-type Ca2+ channels in PC12 cells. Cell Calcium (2008) 0.82
Stabilizers of neuronal and mitochondrial calcium cycling as a strategy for developing a medicine for Alzheimer's disease. ACS Chem Neurosci (2012) 0.82
Neuroprotection by nicotine in hippocampal slices subjected to oxygen-glucose deprivation: involvement of the alpha7 nAChR subtype. J Mol Neurosci (2006) 0.82
Smaller quantal size and faster kinetics of single exocytotic events in chromaffin cells from the APP/PS1 mouse model of Alzheimer's disease. Biochem Biophys Res Commun (2012) 0.82
Increase of angiotensin-converting enzyme activity and peripheral sympathetic dysfunction could contribute to hypertension development in streptozotocin-induced diabetic rats. Diab Vasc Dis Res (2013) 0.82
Emergent cerebrovascular disease risk factor weighting: is transient ischemic attack an imminent threat? Cerebrovasc Dis (2009) 0.81
Albumin prevents mitochondrial depolarization and apoptosis elicited by endoplasmic reticulum calcium depletion of neuroblastoma cells. Eur J Pharmacol (2005) 0.81
Effects of memantine and galantamine given separately or in association, on memory and hippocampal neuronal loss after transient global cerebral ischemia in gerbils. Brain Res (2008) 0.81
Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP. Curr Opin Neurol (2016) 0.81
Nanomolar ouabain elicits apoptosis through a direct action on HeLa cell mitochondria. Steroids (2013) 0.81
New tacrine-dihydropyridine hybrids that inhibit acetylcholinesterase, calcium entry, and exhibit neuroprotection properties. Bioorg Med Chem (2008) 0.80
Poststress treatment with PNU282987 can rescue SH-SY5Y cells undergoing apoptosis via α7 nicotinic receptors linked to a Jak2/Akt/HO-1 signaling pathway. Free Radic Biol Med (2010) 0.80
Novel multitarget ligand ITH33/IQM9.21 provides neuroprotection in in vitro and in vivo models related to brain ischemia. Neuropharmacology (2012) 0.80
[Pseudozyma sp.: colonizer of the respiratory tract in critical patients]. Enferm Infecc Microbiol Clin (2003) 0.80
Single-vesicle catecholamine release has greater quantal content and faster kinetics in chromaffin cells from hypertensive, as compared with normotensive, rats. J Pharmacol Exp Ther (2007) 0.80
Plasmalemmal sodium-calcium exchanger shapes the calcium and exocytotic signals of chromaffin cells at physiological temperature. Am J Physiol Cell Physiol (2013) 0.79
Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives. Eur J Med Chem (2011) 0.79
The adult macaque spinal cord central canal zone contains proliferative cells and closely resembles the human. J Comp Neurol (2014) 0.79
Acetylcholine and potassium elicit different patterns of exocytosis in chromaffin cells when the intracellular calcium handling is disturbed. Pflugers Arch (2002) 0.79
New multipotent tetracyclic tacrines with neuroprotective activity. Bioorg Med Chem (2006) 0.79
The influence of obesity on the assessment of carotid intima-media thickness. J Clin Ultrasound (2012) 0.79
Endovascular treatment of distal internal carotid artery occlusions with retrievable stents. Eur Neurol (2013) 0.79
Distinct protein kinases regulate SNAP-25 expression in chromaffin cells. J Neurosci Res (2003) 0.79
Stochastic entropy QSAR for the in silico discovery of anticancer compounds: prediction, synthesis, and in vitro assay of new purine carbanucleosides. Bioorg Med Chem (2005) 0.79
A neural extracellular matrix-based method for in vitro hippocampal neuron culture and dopaminergic differentiation of neural stem cells. BMC Neurosci (2013) 0.79
A DNA vaccine encoding genetic fusions of carcinoembryonic antigen (CEA) and granulocyte/macrophage colony-stimulating factor (GM-CSF). Vaccine (2005) 0.79
Inhibition of N and PQ calcium channels by calcium entry through L channels in chromaffin cells. Pflugers Arch (2009) 0.79
Greater cytosolic and mitochondrial calcium transients in adrenal medullary slices of hypertensive, compared with normotensive rats. Eur J Pharmacol (2010) 0.79
Mitochondrial Na+/Ca2+-exchanger blocker CGP37157 protects against chromaffin cell death elicited by veratridine. J Pharmacol Exp Ther (2009) 0.79
Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress. J Neurochem (2007) 0.79
Calcium entry through slow-inactivating L-type calcium channels preferentially triggers endocytosis rather than exocytosis in bovine chromaffin cells. Am J Physiol Cell Physiol (2011) 0.78
Dual inhibitors of monoamine oxidase and cholinesterase for the treatment of Alzheimer disease. Curr Top Med Chem (2013) 0.78
Mitochondrial Na+/Ca2+ exchanger, a new target for neuroprotection in rat hippocampal slices. Biochem Biophys Res Commun (2010) 0.78
Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's disease. J Med Chem (2009) 0.78
Resveratrol augments nitric oxide generation and causes store calcium release in chromaffin cells. Eur J Pharmacol (2012) 0.78
Carotid intima-media thickness is inversely associated with olive oil consumption. Atherosclerosis (2007) 0.78
A low nicotine concentration augments vesicle motion and exocytosis triggered by K(+) depolarisation of chromaffin cells. Eur J Pharmacol (2008) 0.78
Focusing on new monoamine oxidase inhibitors: differently substituted coumarins as an interesting scaffold. Curr Top Med Chem (2012) 0.78
On the antiatherogenity of calcium channel blockers: studies in proliferating vascular smooth muscle cells on age sensitivity, dose dependent inhibitory effect, and time of action. Arch Gerontol Geriatr (2004) 0.78
A two-step model for acetylcholine control of exocytosis via nicotinic receptors. Biochem Biophys Res Commun (2007) 0.78